[关键词]
[摘要]
目的:遵循量表编制的规范程序,据课题组前期已有的易怒体质调查表初步编制愤怒郁怒体质量表,检验其信度和效度。方法:采取多阶段分层整群抽样的方式,对大学生、护士、工人3个职业2675人进行问卷调查,考评量表的信度及效度。结果:量表的重测信度在0.712~0.800,分半信度为0.896,克朗巴赫α系数总表为0.899,除形体表征维度的系数低于0.7外,其余各维度的α系数均在0.7以上。量表各维度与总量表呈高度相关,相关系数在0.7以上。该量表结构效度,方差累计贡献率为55.794%,每个条目在其对应的公因子上的载荷都大于0.4,符合逻辑关系。区分效度显示该量表能够区分愤怒与郁怒人群,两组比较及分别与正常人群比较,所得各维度分及量表总分均有极显著性差异(P<0.001)。结论:信度效度考核证明,愤怒郁怒体质量表达到了制作的考核要求,具有高信度、高效度,能较全面地反映愤怒郁怒体质人群的体质特征,可以试用于评价愤怒郁怒人群的体质。
[Key word]
[Abstract]
The aim of this study was to construct an angry-in\out constitution scale according to the standard scale establishment procedure and the scale of anger constitution, and to analyze its reliability and validity. Questionnaire was used in evaluating the multistage stratified cluster sampling method. Tendency of dispersion method, distinction of analysis, exploratory factor analysis, Cronbach's α coefficient method and binary, logistic analysis were used to analyze the reliability and validity of the scale. All statistic analysis was finished by SPSS13.0. The reliability: test-retest reliability 0.712-0.800; split-half reliability 0.896, Cronbach′s α = 0.899. The exploratory factor analysis revealed that the structure validity had logic relation with the cumulative variance of 55.794%. The common charges on each item were all larger than 0.400(min 0.466 and max 0.868). The interior correlation coefficient was above 0.7 between the total scale score and its subdivision dimension score(except the morphological characteristics dimension). The validity of the scale effectively distinguished the anger-in and anger-out population. All dimension scores and the total score of the scale were statistically different (P<0.001) between the angry-in\out groups and the none-trait angry population. The scale of angry-in\out constitution, as a sensitive, effective and reliable test tool which covers all the aspects of angry constitution, may be used to evaluate the angry constitution of populations.
[中图分类号]
[基金项目]
国家重点基础研究发展计划(“973”计划)资助课题(2006CB504804):愤怒和郁怒诱发情志病证发病机制及干预,负责人:乔明琦,张惠云;科学技术部“十一五”国家科技支撑计划课题(2006BAI08B05-10):调肝方药干预经前期综合征肝气逆证的代谢机制,负责人:张惠云。